Pharmaceutical formulations comprising amoxicillin and clavulanate

Details for Australian Patent Application No. 2004246811 (hide)

Owner Glaxo Group Limited

Inventors Ramsey, Michael Gale; Rickman, Jill Tracy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004246811

PCT Pub. Number WO2004/110441

Priority 60/478,769 16.06.03 US; 0313913.6 16.06.03 GB

Filing date 15 June 2004

Wipo publication date 23 December 2004

International Classifications

A61K 31/43 (2006.01)

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/110441 Priority application(s): WO2004/110441

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004246812-Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

2004246800-2-aminopyrimidine derivatives as Raf kinase inhibitors